NRIX vs SO · rev $54.5M vs P/E 22, rev $29.55B
Nurix Therapeutics Inc (NRIX) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
NRIX currently screens at market cap $1.77B. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the NRIX and SO stock pages for the full models.
Not investment advice.